Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001968202-23-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-15 | 2023-11-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $270.43 | +20.0K | 79.4K | +34% | +$5.41M |
| D | 2023-11-15 | 2023-11-13 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $795.69 | -13.5K | 65.9K | -17% | -$10.75M |
| DM | 2023-11-15 | 2023-11-14 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $799.17 | -6,492 | 59.4K | -10% | -$5.19M |
| D | 2023-11-15 | 2023-11-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -20.0K | 20.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | M | A | 20,000 | $270.43 | 79,421 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-13 | F | D | 13,508 | $795.69 | 65,913 | D | — | — | |
| 3 | Common | Common Stock | 2023-11-14 | S | D | 752 | $794.57 | 65,161 | D | — | — | (F2) Represents volume-weighted average price of sales of 752 shares of Company stock on November 14, 2023 at prices ranging from $794.03 to $794.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-11-14 | S | D | 347 | $795.38 | 64,814 | D | — | — | (F3) Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $795.02 to $795.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-11-14 | S | D | 204 | $797.79 | 64,610 | D | — | — | (F4) Represents volume-weighted average price of sales of 204 shares of Company stock on November 14, 2023 at prices ranging from $797.09 to $797.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-11-14 | S | D | 1,614 | $798.63 | 62,996 | D | — | — | (F5) Represents volume-weighted average price of sales of 1,614 shares of Company stock on November 14, 2023 at prices ranging from $798.00 to $798.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-11-14 | S | D | 1,601 | $799.48 | 61,395 | D | — | — | (F6) Represents volume-weighted average price of sales of 1,601 shares of Company stock on November 14, 2023 at prices ranging from $799.00 to $799.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 8 | Common | Common Stock | 2023-11-14 | S | D | 382 | $800.55 | 61,013 | D | — | — | (F7) Represents volume-weighted average price of sales of 382 shares of Company stock on November 14, 2023 at prices ranging from $800.31 to $800.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 9 | Common | Common Stock | 2023-11-14 | S | D | 877 | $801.56 | 60,136 | D | — | — | (F8) Represents volume-weighted average price of sales of 877 shares of Company stock on November 14, 2023 at prices ranging from $801.01 to $801.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 10 | Common | Common Stock | 2023-11-14 | S | D | 347 | $802.63 | 59,789 | D | — | — | (F9) Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $802.17 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 11 | Common | Common Stock | 2023-11-14 | S | D | 330 | $803.38 | 59,459 | D | — | — | (F10) Represents volume-weighted average price of sales of 330 shares of Company stock on November 14, 2023 at prices ranging from $803.18 to $803.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price. |
| 12 | Common | Common Stock | 2023-11-14 | S | D | 19 | $804.89 | 59,440 | D | — | — | |
| 13 | Common | Common Stock | 2023-11-14 | S | D | 19 | $805.00 | 59,421 | D | — | — | |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-11-13 | M | D | 20,000 | $0.00 | 20,000 | D | $270.43 · — to 2023-12-13 | 20,000 Common Stock | (F11) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |